Vedolizumab in Pediatric inflammatory bowel diseases: a retrospective multi-center experience from the paediatric IBD Porto group of ESPGHAN by Ledder, O, De Meij, T, Martín De Carpi, J, Richmond, L, Cohen, S, Bronsky, J, Shaoul, R, Levine, A, Escher, J, Deridder, L, Assa, A, Ruemmele, F, Shah, N, Wolters, V, Rodrigues, A, Uhlig, H, Urlep, D, Posovsky, C, Kolho, K, Turner, D

Vedolizumab in paediatric Inflammatory Bowel Disease: A retrospective multi-centre experience From the paediatric IBD Porto Group of ESPGHAN by Ledder, O, Assa, A, Levine, A, Escher, J, De Ridder, L, Ruemmele, F, Shah, N, Shaoul, R, Wolters, V, Rodrigues, A, Uhlig, H, Posovsky, C, Kolho, K, Jakobsen, C, Cohen, S, Shouval, D, de Meij, T, Martin-de-Carpi, J, Richmond, L, Bronsky, J, Friedman, M, Turner, D

Vedolizumab in pediatric inflammatory bowel disease: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN by Ledder, O, Assa, A, Levine, A, Escher, J, de Ridder, L, Ruemmele, F, Shah, N, Shaoul, R, Wolters, V, Rodrigues, A, Uhlig, H, Posovsky, C, Kolho, K, Jakobsen, C, Cohen, S, Shouval, D, de Meij, T, Martin-de-Carpi, J, Richmond, L, Bronsky, J, Friedman, M, Turner, D